BHC Bausch Health Companies Inc.: Net earnings per share growth forecast for next year

Corporate emblem and logo of Bausch Health Companies (BHC)

Bausch Health Companies (BHC) is overcoming stagnation by updating its product line for the global market. On GURU.Markets, this chart of the company's expected EPS growth for the coming year shows that the current metric is -13.90. Success is based on the cash flows of the Bausch + Lomb and Salix brands, although the debt burden and the expansion of cheap generics create serious risks for the business.

BHC: Bausch Health Companies Inc. Net earnings per one share growth forecast for next year 07/04/2022 - 11/15/2026

Analytical breakdowns and data insights for company Valeant Pharmaceuticals (BHC)

- share price and consensus valuation forecast:
Stock Price bauschhealth.com|BHC - Analyst Median Target
- company stock capitalization data:
Market Value Bausch Health Corp|BHC - Business Value
- company book value details:
Book Value per Share Bausch Health|BHC - Book Value of Business|Market Capitalization to Book Value Ratio bauschhealth.com|BHC - Aggregate Company Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Bausch Health Companies|BHC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Bausch Health Companies Inc.|BHC - Company Aggregate Debts|Debt to Book Capitalization Ratio Bausch Health Corp|BHC - Long-Term Debt Volume|Company Short-Term Debts Bausch Health|Quick Ratio bauschhealth.com
- earnings and valuation multiples information:
BHC - Final Profit|Future Profit Bausch Health Companies|BHC - Company Value to Net Income|Forward P/E Multiple Bausch Health|BHC - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Bausch Health|BHC - Profit before interest, taxes and amortization|Net earnings per share (EPS TTM) Bausch Health|BHC - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months bauschhealth.com|BHC - Earnings per share growth in current year|Expected earnings per share growth for next year Bausch Health Companies
- sales and revenue data:
BHC - Company Total Sales|Projected Sales Volume Bausch Health Companies|BHC - Market Capitalization-to-Revenue Ratio|Forward Price-to-Revenue Multiple Valeant Pharmaceuticals|BHC - Revenue Dynamics YoY (Last Twelve Months)
Basic company analysis:BHC, bauschhealth.com
Finished products of Bausch Health Companies Inc.

Bausch Health Companies (BHC) relies on stable revenue from its ophthalmology segment, yet high debt and patent disputes create uncertainty for the bottom line. This indicator measures the expected EPS dynamics for the coming year, allowing investors to assess market expectations regarding business growth rates by analyzing changes in earnings per share target estimates to identify hidden risks or asset undervaluation.

Competitor analysis

LLY (lilly.com) - Earnings growth forecast for next year|Projected earnings per share growth rate for next year ABBV (AbbVie Inc.)|Net earnings per share growth forecast for next year AstraZeneca AB (AZN)|Novartis - Projected earnings per share growth rate for next year|Earnings growth forecast for next year MRK (Merck & Co.)|Net earnings per one share growth forecast for next year Novo Nordisk Group|Amgen Inc - Earnings growth forecast for next year|Net earnings per share change forecast for next year PFE|SNY: Earnings growth forecast for next year|Bristol Myers Squibb - Expected earnings per share trend next year|Net earnings per share growth forecast for next year GSK Corp|Earnings growth forecast for next year Takeda Pharmaceutical Company Limited|Expected earnings per share growth for next year TEVA (Teva Pharmaceutical Industries)|RDY (drreddys.com) - Expected earnings per share trend next year|Viatris Inc. - Expected earnings per share growth for next year|Roivant Sciences - Net earnings per share growth forecast for next year|ZLAB - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Cosmos Health Inc